Enanta Pharmaceuticals | ENTA - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 21.73B 3B 2026-05
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 13.34B 800M 2026-05
Novartis USD 232.75B 75B 2026-05
Novavax USD 1.09B 316M 2025-12
Pfizer USD 148.08B 6.51B 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05